Hamza Kandoussi

Assessment of Pharmacokinetic Interactions of the HCV Ns5A Replication Complex Inhibitor Daclatasvir with Antiretroviral Agents: Ritonavir-Boosted Atazanavir, Efavirenz and Tenofovir

Marc Bifano, Carey Hwang, B. Oosterhuis et al. · Antiviral Therapy · 2013 · 92 citations

Multiplexed LC-MS/MS method for the simultaneous quantitation of three novel hepatitis C antivirals, daclatasvir, asunaprevir, and beclabuvir in human plasma

Hao Jiang, Hamza Kandoussi, Jianing Zeng et al. · Journal of Pharmaceutical and Biomedical Analysis · 2015 · 62 citations

Multiplexed Lc-ms/ms Method, Viral Hepatitis, Immunology +9

Further Studies to Support the Use of Coproporphyrin I and III as Novel Clinical Biomarkers for Evaluating the Potential for Organic Anion Transporting Polypeptide 1B1 and OATP1B3 Inhibition

Hong Shen, Lisa J. Christopher, Yurong Lai et al. · Drug Metabolism and Disposition · 2018 · 55 citations · Full text

Single-Dose Pharmacokinetics and Safety of Daclatasvir in Subjects with Renal Function Impairment

Τushar Garimella, Reena Wang, Wen‐Lin Luo et al. · Antiviral Therapy · 2014 · 49 citations · Full text

Practical and Efficient Strategy for Evaluating Oral Absolute Bioavailability with an Intravenous Microdose of a Stable Isotopically-Labeled Drug Using a Selected Reaction Monitoring Mass Spectrometry Assay

Hao Jiang, Jianing Zeng, Wenying Li et al. · Analytical Chemistry · 2012 · 40 citations

Biological Mass Spectrometry, Intravenous Microdose, Pharmacodynamic Modeling +21